100
Participants
Start Date
August 1, 2024
Primary Completion Date
March 31, 2026
Study Completion Date
August 31, 2026
Dexmedetomidine Hydrochloride
Initial dexmedetomidine bolus of 1 mcg/kg over 30 min after induction, followed by an infusion rate of 0.3 mcg/kg/hr that will be stopped 30-45 minutes before the end of the surgery or once a maximum dose of 2mcg/kg has been achieved, whichever comes first.
Placebo
normal saline infusion
RECRUITING
Brigham and Women's Hospital, Boston
Brigham and Women's Hospital
OTHER